News Conference News EuroPCR 2019 TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out Caitlin E. Cox May 24, 2019
News Conference News EuroPCR 2018 NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years Caitlin E. Cox May 24, 2018
News Conference News EuroPCR 2018 Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted Caitlin E. Cox May 23, 2018
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017